Jove
Visualize
联系我们

相关概念视频

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

387
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
387

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The Expanding Role of Artificial Intelligence in Companion Animal Care: A Systematic Review.

Animals : an open access journal from MDPI·2026
Same author

Intracardiac Echocardiography during Invasive Electrophysiological Procedures: a Scientific Statement of the European Heart Rhythm Association of the ESC, and the European Association of Percutaneous Cardiovascular Interventions of the ESC.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

Time to rethink ICD indications in non-ishaemic cardiomyopathy? Evidence from a meta-analysis across therapeutic eras.

ESC heart failure·2026
Same author

Durability of Exercise vs. Revascularization in Intermittent Claudication: An Updated Meta-Analysis of Randomized Trials Focusing on Patient-Centered Outcomes.

Healthcare (Basel, Switzerland)·2026
Same author

Improving Risk Stratification in Sudden Cardiac Death Using Interpretable Machine Learning: A Clinical Perspective.

Healthcare (Basel, Switzerland)·2025
Same author

Completely Fluoroless, "Apron-Less" Approach to Supraventricular Tachycardia Ablation Compared to Traditional Fluoroscopy Guided Ablation: Feasibility, Safety and Clinical Outcomes.

Journal of clinical medicine·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jan 13, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

26.8K

基于机器学习的急性心脏病死亡风险分层,使用临床和设备衍生数据.

Hana Ivandic1, Branimir Pervan1, Mislav Puljevic2,3

  • 1University of Zagreb Faculty of Electrical Engineering and Computing, Unska 3, HR-10000 Zagreb, Croatia.

Sensors (Basel, Switzerland)
|January 10, 2026
PubMed
概括

机器学习模型在预测突然心脏死亡 (SCD) 风险方面表现有前途,改善了患者选择植入式心脏转换器-除器 (ICD) 的情况. 这些模型实现了高回忆率,比目前的方法更有效地识别需要干预的患者.

关键词:
在SHAP分析中,我们分析了SHAP.可植入式心脏转换器除器机器学习是机器学习.突然的心脏病死亡.

更多相关视频

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.0K

相关实验视频

Last Updated: Jan 13, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

26.8K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.0K

科学领域:

  • 心脏病学 心脏病学
  • 生物医学工程 生物医学工程
  • 数据科学数据科学数据科学

背景情况:

  • 突然心脏死亡 (SCD) 构成了重大的临床挑战.
  • 植入式心脏变压器 (ICD) 是SCD的主要预防措施.
  • 目前对ICD患者的选择依赖于不完美的风险标志物.

研究的目的:

  • 评估机器学习 (ML) 模型在改善SCD风险预测方面的潜力.
  • 利用表格式的临床数据,包括心电图和ICD衍生特征,以加强风险评估.
  • 通过先进的预测分析来完善患者选择ICD植入.

主要方法:

  • 在各种患者数据上训练了各种ML模型 (随机森林,天真贝叶斯,后勤回归,投票分类器).
  • 包括人口,临床,实验室和设备衍生变量.
  • 优化了F2得分的模型,以优先考虑高风险患者的检测,并使用SHAP值进行解释.

主要成果:

  • 随机森林模型获得了最高的F2得分 (0.74) 和高回忆率 (97.30%).
  • 投票分类器显示了最好的整体歧视 (AUC-ROC 0.76).
  • 机器学习模型成功地确定了已知和潜在的SCD预测因子,证实了它们的预测能力.

结论:

  • 机器学习模型显示了改进患者选择ICD的巨大潜力.
  • 通过ML模型实现的高回忆率表明,对SCD高风险个体的检测有所改善.
  • 基于ML的风险预测为改善心血管保健和减少SCD发病率提供了一个有希望的途径.